EXAGEN INC.
Data quality: 100%
XGN
NASDAQ
Services
Health Services
$3.07
▲
$0.03
(0.99%)
6 months return
—
Momentum
Neutral
5Y revenue growth
8.35%
Growth
Revenue Growth (5Y)
8.35%
Above sector avg (4.21%)
Revenue (1Y)19.65%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-101.86%
Below sector avg (-16.21%)
ROIC-22.59%
Net Margin-29.97%
Op. Margin-21.13%
Safety
Debt / Equity
1.26
Above sector avg (0.39)
Current Ratio4.08
Interest Coverage-3.26
Valuation
PE (TTM|NTM)
-3.73 | -9.77
Below sector avg (-1.17)
P/B Ratio4.10
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 8.35% annually over 5 years — modest growth
Negative free cash flow of -14.27 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 11.30%
Capital efficient — spends only 0.96% of revenue on capex
Price History
Financial Trends
Analyst Price Target
6 analysts
Buy
+209.4%
upside to target
Current
$3.07
Consensus Target
$9.50
$8.00
Low
$10.00
High
Forecast
Forward P/E
-9.77
Forward EPS
-$0.31
Est. Revenue
79.74 M
Earnings Surprises
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -$0.25
·
Rev Est: 16.32 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -$0.20 | -$0.18 | -$0.31 | -$0.27 | — | — |
| Estimate | -$0.21 | -$0.15 | -$0.16 | -$0.19 | -$0.25 | -$0.20 |
| Surprise | +3.23% | -18.78% | -96.83% | -37.69% | — | — |
Growth
Rev 5Y: 8.35% · Earnings 1Y: N/A
Growth
Rev 5Y: 8.35% · Earnings 1Y: N/A| Revenue Growth (1Y) | 19.65% | Revenue Growth (3Y) | 12.56% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 8.35% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -101.86% · Net Margin: -29.97%
Profitability
ROE: -101.86% · Net Margin: -29.97%| Revenue (TTM) | 66.58 M | Net Income (TTM) | -19.95 M |
| ROE | -101.86% | ROA | -32.82% |
| Gross Margin | 58.28% | Operating Margin | -21.13% |
| Net Margin | -29.97% | Free Cash Flow (TTM) | -14.27 M |
| ROIC | -22.59% | FCF Growth (3Y) | N/A |
Safety
D/E: 1.26 · Current: 4.08
Safety
D/E: 1.26 · Current: 4.08| Debt / Equity | 1.26 | Current Ratio | 4.08 |
| Interest Coverage | -3.26 | Asset Turnover | 1.10 |
| Working Capital | 39.70 M | Tangible Book Value | 18.14 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -3.73 · EV/EBITDA: N/A
Valuation
P/E: -3.73 · EV/EBITDA: N/A| P/E Ratio | -3.73 | Forward P/E | -9.77 |
| P/B Ratio | 4.10 | P/S Ratio | 1.12 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 0.93 | Fwd Earnings Yield | N/A |
| FCF Yield | -19.19% | ||
| Market Cap | 74.32 M | Enterprise Value | 61.61 M |
Per Share
EPS: -0.93 · FCF/Share: -0.59
Per Share
EPS: -0.93 · FCF/Share: -0.59| EPS (Diluted TTM) | -0.93 | Revenue / Share | 2.77 |
| FCF / Share | -0.59 | OCF / Share | -0.57 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 71.51% · CapEx/Rev: 0.96%
Efficiency
FCF Conv: 71.51% · CapEx/Rev: 0.96%| CapEx / Revenue | 0.96% | FCF Conversion | 71.51% |
| SBC-Adj. FCF | -15.94 M | Growth Momentum | 11.30 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 66.58 M | 55.64 M | 52.55 M | 45.56 M | 48.30 M |
| Net Income | -19.95 M | -15.12 M | -23.69 M | -47.39 M | -26.85 M |
| EPS (Diluted) | -0.93 | -0.83 | -1.34 | -2.77 | -1.68 |
| Gross Profit | 38.80 M | 33.11 M | — | — | — |
| Operating Income | -14.07 M | -13.64 M | -22.84 M | -46.05 M | -24.07 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 6.25 M | 5.38 M | 4.87 M | 9.88 M | 7.24 M |
| SG&A Expenses | 46.62 M | 41.37 M | 47.43 M | 52.02 M | 44.54 M |
| D&A | 2.10 M | 1.70 M | 2.20 M | 1.60 M | 900,000.0 |
| Interest Expense | 4.32 M | 2.23 M | 2.34 M | 2.45 M | 2.63 M |
| Income Tax | 51,000.0 | 12,000.0 | 33,000.0 | -282,000.0 | 175,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 58.02 M | 44.69 M | 56.94 M | 86.22 M | 123.45 M |
| Total Liabilities | 40.57 M | 35.15 M | 34.25 M | 43.76 M | 38.51 M |
| Shareholders' Equity | 17.45 M | 9.54 M | 22.69 M | 42.46 M | 84.94 M |
| Total Debt | 22.91 M | 20.25 M | 19.50 M | 28.97 M | 27.48 M |
| Cash & Equivalents | 32.22 M | 22.04 M | 36.49 M | 62.39 M | 99.44 M |
| Current Assets | 48.89 M | 36.46 M | 47.84 M | 72.61 M | 112.73 M |
| Current Liabilities | 14.16 M | 13.51 M | 11.90 M | 9.62 M | 9.32 M |
Peer Comparison
vs Services sector median (615 peers)
Compared with similar companies in Services
Peer Comparison
vs Services sector median (615 peers) Compared with similar companies in Services| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -3.7 | -1.2 |
| P/B | 4.1 | 1.4 |
| ROE % | -101.9 | -16.2 |
| Net Margin % | -30.0 | -19.4 |
| Rev Growth 5Y % | 8.4 | 4.2 |
| D/E | 1.3 | 0.4 |
{"event":"ticker_viewed","properties":{"ticker":"XGN","listing_kind":"stock","pathname":"/stocks/xgn","exchange":"NASDAQ","country":"US"}}